£18.5M
The funding was awarded through the DRIVE35 Scale-Up Fund to build the ACT3 facility in Plymouth.
Innovate UK
GovernmentInnovate UK is a government-backed agency supporting business-led innovation across the United Kingdom.
Recent investments
£2.4M
The funding round was co-led by TSP Ventures and Boast Trading to help establish the company's first commercial pilot plant.
"Our unique ionic liquid platform can create nanoparticles tuned for high performance in high-value applications. With the same platform, we can recover valuable raw materials from waste sources and mineral ores,"
TSP Ventures + 6 others
£3.2M
The Cardiff-based agricultural technology company secured funding to scale international operations and advance its autonomous software ecosystem.
"Bringing GreenFingers to market simply wouldn’t have been possible at this pace without Foresight’s backing. Their investment has enabled us to turn an ambitious concept into meaningful value for growers. GreenFingerscreates a truly autonomous self-optimising lighting ecosystem, using advanced algorithms to determine the optimal supplementary intensity and spectrum. It automatically adjusts LED fixtures in real time to maintain a consistent DLI under a balanced cultivation environment."
£100K
Mint Ventures led the investment round with co-investment from Alma Angels and Lifted Ventures.
"We are thrilled to support My Bliss and their visionary team. Their commitment to improving women’s health through evidence-based innovation aligns perfectly with our mission to back diverse founders who are changing the world for the better. We believe My Bliss is poised to make a significant difference to women’s health, and we’re excited to be part of their journey."
£2.9M
The Norwich-based drug discovery startup emerged from stealth with backing from SynBioVen, Start Codon, UKI2S, Twin Path Ventures, Wren Capital, angels, and Innovate UK.
"We grow greener medicines using a platform that makes the impossible accessible. The drug discovery field desperately needs new chemical space and the vaccine field needs new adjuvants, with supply chains that work for everyone. By combining AI with plant engineering, we can reach molecules others cannot, and scale them in a way that supports global health, not just high-income markets."
